Hansa Biopharma participating in Wedbush PacGrow Renal Summit

giovedì 2 luglio 2026 New tab

240 words~1 min read

PR Newswire

LUND, Sweden, July 2, 2026

LUND, Sweden, July 2, 2026 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced that Maria Törnsén, COO and President U.S., Hansa Biopharma, will participate in a fireside chat titled "Don't Be So Sensitive - Bringing Kidneys to the Over-Sensitized" with Dr. Leonardo Riella, Massachusetts General Hospital, at the Wedbush PacGrow Renal Summit in Boston, at 1:10 PM EDT on Wednesday, July 8, 2026.

View original content:https://www.prnewswire.com/news-releases/hansa-biopharma-participating-in-wedbush-pacgrow-renal-summit-302816848.htmlSOURCE Hansa Biopharma AB

Hansa Biopharma participating in Wedbush PacGrow Renal Summit

Hansa Biopharma participating in Wedbush PacGrow Renal Summit

Related reading

Spago Nanomedical Presents Tumorad(R) Clinical Data at the International ANZSNM…

Hansa Biopharma enters into €115 million licensing agreement with SERB…

BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare…

Vicore Pharma to Present at the Jefferies Global Healthcare Conference

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT GOLDMAN SACHS ANNUAL GLOBAL…

The Subscription Period in Spago Nanomedical's Rights Issue Begins Today

Related reading

Spago Nanomedical Presents Tumorad(R) Clinical Data at the International ANZSNM…

Hansa Biopharma enters into €115 million licensing agreement with SERB…

BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare…

Vicore Pharma to Present at the Jefferies Global Healthcare Conference

UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT GOLDMAN SACHS ANNUAL GLOBAL…

The Subscription Period in Spago Nanomedical's Rights Issue Begins Today